IPCPR Legislative | IPCPR Testifies at Small Business Administration’s 2017 National Regulatory Fairness Hearing

IPCPR Testifies at Small Business Administration’s 2017 National Regulatory Fairness Hearing

05 Sep IPCPR Testifies at Small Business Administration’s 2017 National Regulatory Fairness Hearing

Last week, IPCPR Vice President John Anderson testified before the Small Business Administration (SBA) on behalf of our member retailers across the country. His testimony was part of SBA’s 2017 National Regulatory Fairness Hearing facilitated by the Office of the Ombudsman. According to the SBA,  the purpose of this forum was to give small businesses and the organizations that represent them an opportunity to identify unfair and harmful federal regulations directly or indirectly affecting their ability to do business.

As both a leader within IPCPR and a small business retailer, John Anderson’s testimony laid bare the challenges facing tobacconists, like himself, across the country due to FDA’s regulatory zeal. According to Anderson, this was a great opportunity to raise awareness and generate advocates within the federal government itself: “The SBA’s mission is to represent, protect and support small businessmen and women – the kind that make up IPCPR’s membership. The hope is that this testimony helps bring other parts of the federal government onto our side.”

With only seven minutes of testimony, Anderson highlighted for the ombudsman the pending compliance deadlines, faulty economic impact reviews and the potential for job loss all tied to the FDA’s Deeming Rule.  Anderson explained that the FDA mission to prevent youth initiation to tobacco is not assisted by targeting cigars and premium tobacco.  Anderson called on the SBA to take action because “The rule has created burdensome costs for businesses, without actually achieving any real purpose.”

IPCPR is grateful for the invitation and opportunity to testify before the SBA’s Office of the Ombudsman. This is another positive step in the ongoing fight against onerous and ineffective FDA regulations and continues to raise our concerns with an administration that prioritizes deregulation and support for small businesses. The association board, our staff and our partners in Washington will continue to advocate on behalf of our members and work to ultimately allow them to sell premium tobacco products without threat of crushing regulatory overreach.

For additional questions on the National Regulatory Fairness Hearing or on IPCPR’s activities in Washington, please contact Daniel Trope, IPCPR Director of Federal Government Affairs at daniel@ipcpr.org.



CONTACT IPCPR LEGISLATIVE
Questions? Comments? Interested in Getting Involved? Contact the IPCPR Legislative Team!
CONTACT US
Thank You. We will contact you as soon as possible.